1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy

Technology appraisal guidance [TA613] Published: 20 November 2019

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 158 KB 20 November 2019  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 260 KB 17 October 2019  
  • Committee papers PDF 705 KB 17 October 2019  
  • Public committee slides PDF 482 KB 17 October 2019  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document (PDF version) PDF 267 KB 31 July 2019  
  • Appraisal consultation document (online commenting)  
  • Committee papers PDF 7.05 MB 31 July 2019  
  • Public committee slides PDF 338 KB 31 July 2019  

Invitation to participate

  • Final scope PDF 216 KB 24 October 2018  
  • Final matrix PDF 255 KB 24 October 2018  
  • Equality impact assessment (Scoping) PDF 179 KB 24 October 2018